SCHEMBL22340481

SCHEMBL22340481

C=CCN(CC)Cc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
KCNH2 Q12809 3/20 0.48
CRHBP P24387 1/20 0.47
CRHR2 Q13324 1/20 0.47
PYCR1 P32322 1/20 0.46
LOXL2 Q9Y4K0 1/20 0.42
KDM4E B2RXH2 1/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
HTT P42858 1/20 0.42
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
TSHR P16473 1/20 0.40
CYP19A1 P11511 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31588864 0.91 PYCR1 (0.50) CYP1A2CYP2D6CYP2C9CYP2C19KCNH2
SCHEMBL3157181 0.85 CYP2C19 (0.59) CYP1A2CYP2D6CYP2C9CYP2C19KCNH2
SCHEMBL3156936 0.85 CRHBP (0.54) CYP1A2CYP2D6CYP2C9CYP2C19CRHBP
SCHEMBL29336516 0.81 PYCR1 (0.59) KCNH2CRHBPCRHR2PYCR1LOXL2
SCHEMBL3161766 0.80 CYP1A2 (0.75) CYP1A2CYP2D6CYP2C9CYP2C19KCNH2
SCHEMBL15392240 0.78 LOXL2 (0.59) CYP1A2CYP2D6CYP2C9CYP2C19KCNH2
SCHEMBL20871858 0.77 CNR2 (0.49) KCNH2PYCR1HRH3
SCHEMBL28042128 0.77 ALDH1A1 (0.52) CYP2D6CYP2C9CYP2C19KCNH2CRHBP
SCHEMBL1206139 0.76 HRH3 (0.58) CYP1A2CYP2D6CYP2C9CYP2C19KCNH2
SCHEMBL22340499 0.76 PYCR1 (0.64) PYCR1KDM4EALDH1A1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11034646-B2 Method for the synthesis of unsymmetrical tertiary amines Universite Paris-Saclay (FR) 2021-06-15 US disclosed
US-20200255369-A1 NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES Universite Paris-Saclay (FR) 2020-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200255369-A1 NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES ADH1C, ADH1A, ADH5 CYP1A2 204/4885CYP2D6 2652/4885CYP2C9 1888/4885
US-11034646-B2 Method for the synthesis of unsymmetrical tertiary amines ADH1C, PNMT, ADH1A CYP1A2 169/4885CYP2D6 2314/4885CYP2C9 1585/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.